Capital World Investors - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 68 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Capital World Investors ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,884,000
-87.6%
2,214,200
-19.5%
0.00%
-100.0%
Q1 2022$15,158,000
-43.1%
2,751,0000.0%0.00%
-25.0%
Q4 2021$26,630,000
-43.8%
2,751,000
+3.8%
0.00%
-50.0%
Q3 2021$47,400,000
+33.9%
2,651,000
+82.8%
0.01%
+33.3%
Q2 2021$35,403,000
-7.9%
1,450,3330.0%0.01%
-14.3%
Q1 2021$38,434,000
+353.3%
1,450,333
+29.8%
0.01%
+250.0%
Q4 2020$8,478,000
+51.5%
1,117,0000.0%0.00%
+100.0%
Q3 2020$5,596,000
-16.2%
1,117,0000.0%0.00%
-50.0%
Q2 2020$6,680,000
-14.8%
1,117,000
-36.6%
0.00%0.0%
Q1 2020$7,844,000
-84.1%
1,762,598
-66.0%
0.00%
-81.8%
Q4 2019$49,182,000
+104.6%
5,177,000
+69.1%
0.01%
+83.3%
Q3 2019$24,040,000
-50.1%
3,062,3960.0%0.01%
-45.5%
Q2 2019$48,171,000
-13.1%
3,062,3960.0%0.01%
-15.4%
Q1 2019$55,429,000
+15.1%
3,062,3960.0%0.01%0.0%
Q4 2018$48,149,000
-29.1%
3,062,396
+5.9%
0.01%
-23.5%
Q3 2018$67,869,0002,892,3960.02%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Abbot Financial Management, Inc. 1,411,775$25,243,00011.48%
Flagship Pioneering Inc. 38,506,526$688,497,0007.21%
Artal Group S.A. 4,155,625$74,303,0001.66%
HARBOURVEST PARTNERS LLC 986,878$17,645,0001.66%
Nan Fung Group Holdings Ltd 56,768$1,015,0000.32%
Lombard Odier Asset Management (Switzerland) SA 245,013$4,381,0000.27%
Bellwether Advisors, LLC 29,383$525,0000.18%
PDT Partners, LLC 65,991$1,180,0000.08%
Virtus ETF Advisers LLC 7,478$134,0000.06%
HITE Hedge Asset Management LLC 24,911$445,0000.06%
View complete list of RUBIUS THERAPEUTICS INC shareholders